Hemo - on Ortex6 Jun 2024 21:27
Hemo on Ortex ( upto this morning )
- Hemogenyx (HEMO.L) traded up 0.68 % and now trades at GBp 1.452. Current market capitalisation for Hemogenyx is GBp 2 bn. Hemogenyx Flies Under the Radar with Little Recent News Despite a lack of recent news, investors may be keeping a watchful eye on Hemogenyx Pharmaceuticals PLC (LON:HEM), whose shares have seen significant fluctuations over the past year. As of today's market close, the biotech firm's stock has been trading at 1.499 GBp, down from its 52-week high of 7.134 GBp reached on February 8th. A look back at Hemogenyx's historical pricing reveals a rollercoaster ride for shareholders. In June of last year, the stock plummeted to a 52-week low of 1.1 GBp before rebounding sharply in the months that followed. This upward trend continued until early March, when the company announced total voting rights, causing a slight pullback. From a technical standpoint, Hemogenyx's current price sits below both its 50-day moving average (MA) and 200-day MA, which could be interpreted as a sign of weakness. However, the stock's relative strength index (RSI) remains above 50, indicating that bullish momentum may still be present. Investors looking to capitalize on Hemogenyx's potential should keep an eye on future developments, such as clinical trial updates or regulatory approvals. With little recent news, the biotech sector's overall performance will likely have a greater impact on the company's share price than any specific announcements from Hemogenyx itself.
Letβs see what the next few weeks bring π